Biomarker for Cancer
Showing 1 - 25 of >10,000
Clinical Study of QSOX1 as a Biomarker for Colon Cancer
Not yet recruiting
- Colon Cancer
- Diagnosis of colon cancer
- (no location specified)
Apr 21, 2023
Cancer Trial
Not yet recruiting
- Cancer
- (no location specified)
May 25, 2023
Renal Cancer Trial in Aarhus N
Enrolling by invitation
- Renal Cancer
-
Aarhus N, DenmarkUrology Department Aarhus University Hospital
Nov 21, 2023
Patterns Among PIK3CA Mutation in Advanced Breast Cancer
Completed
- Breast Cancer
-
East Hanover, New JerseyNovartis
Aug 1, 2023
Improvement of Vaginal Health in Breast Cancer, ARISE Study
Recruiting
- Breast Neoplasms
- Biospecimen Collection
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 13, 2023
Breast Cancer Trial in Ankara (measurement of serum autotaxin serum level)
Completed
- Breast Cancer
- measurement of serum autotaxin serum level
-
Ankara, TurkeyAnkara Etlik City Hospital
Jan 25, 2023
Uromonitor asBiomarker for Optimization of NMIBC Management by
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- (no location specified)
May 9, 2023
Predict Efficacy of Anti-angiogenic Therapy in Ovarian Cancer
Active, not recruiting
- Epithelial Ovarian Cancer
- liquid biopsy
-
Aviano, ItalyCentro di Riferimento Oncologico (CRO), IRCCS
May 16, 2023
1 asPotential Biomarker for Colorectal Cancer Diagnosis and
Not yet recruiting
- Colorectal Cancer
- Tumor Endothelial Marker 1 ( TEM1 ) by ELISA kits
- (no location specified)
Mar 20, 2023
Metastatic Breast Cancer, Unresectable Breast Cancer Trial in Saint Louis (DiviTum® TKa assay, CDK4/6 + Endocrine therapy)
Not yet recruiting
- Metastatic Breast Cancer
- Unresectable Breast Cancer
- DiviTum® TKa assay
- CDK4/6 + Endocrine therapy
-
Saint Louis, MissouriWashington University School of Medicine
Jul 27, 2023
Colorectal Cancer, Anesthesia, Cancer Metastatic Trial (Lidocaine IV, Dexmedetomidine IV, intrathecal morphine)
Not yet recruiting
- Colorectal Cancer
- +3 more
- Lidocaine IV
- +2 more
- (no location specified)
Feb 14, 2023
Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Seoul (exosome and ctDNA evaluation)
Active, not recruiting
- Triple Negative Breast Cancer
- HER2-positive Breast Cancer
- exosome and ctDNA evaluation
-
Seoul, Korea, Republic ofJi-Yeon Kim
Jul 13, 2023
Development ofDecision Aid to Facilitate Ovarian Cancer
Completed
- Ovarian Cancer
-
Vejle, DenmarkDepartment of Oncology, Vejle Hospital
Feb 2, 2023
Multiparametric MRI asNon-Invasive Biomarker of Tumor
Recruiting
- Breast Cancer
- Triple-negative Breast Cancer
- Tempus assay
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 10, 2023
HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With
Not yet recruiting
- Gastric Cancer
- Observational
- (no location specified)
Dec 13, 2022
Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
Recruiting
- Ovarian Neoplasms
- +2 more
-
Aarhus, DenmarkDepartment of Gynaecology and Obstetrics, Aarhus University Hosp
Mar 9, 2023
Pancreatic Cancer Trial in Goyang-si
Active, not recruiting
- Pancreatic Cancer
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Sep 27, 2022
Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Sao Paulo (cisplatin, gemcitabine, Follow-up)
Not yet recruiting
- Cervical Cancer
- +2 more
- cisplatin, gemcitabine
- Follow-up
-
Sao Paulo, BrazilHospital do Coração - Research Institute
Mar 1, 2023
Serum Insulin-like Growth Factor Binding Protein-3 asPotential
Not yet recruiting
- Colorectal Cancer
- evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer
- (no location specified)
May 6, 2023
Disease Burden, Genetic Heterogeneity and Tumour Evolution in
Recruiting
- Thyroid Cancer
- Sample collection only
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 28, 2023
Immune Biomarker Study for Head and Neck Cancer
Recruiting
- Head and Neck Cancer
- +4 more
- Sampling
-
Erlangen, Bavaria, Germany
- +2 more
Jan 23, 2023
Personalized Urine Biomarker for Patients With Bladder Cancer
Not yet recruiting
- Bladder Neoplasm
- TURBT
- (no location specified)
Jul 17, 2022
Prostate Cancer, Castration-resistant Prostate Cancer Trial in São Paulo (Docetaxel, Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Castration-resistant Prostate Cancer
-
São Paulo, SP, BrazilInstituto do Câncer do Estado de São Paulo
Sep 14, 2022
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
Recruiting
- Lung Cancer
- Plasma protein biomarker analysis
-
Hangzhou, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Feb 23, 2023